Welcome to our dedicated page for Forian SEC filings (Ticker: FORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Forian Inc. (FORA) SEC filings page on Stock Titan provides access to the company’s official regulatory documents filed with the U.S. Securities and Exchange Commission. As a Nasdaq-listed issuer in the data processing and healthcare analytics space, Forian uses these filings to report its financial condition, governance matters, strategic transactions and other material events related to its operations in life sciences, healthcare and financial services analytics.
Through periodic reports such as the Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, Forian presents audited and unaudited financial statements, discussions of results from continuing operations, information on discontinued operations, and details about its large-scale healthcare data assets and information products. These filings also include sections like “Risk Factors” that the company references in its news releases when discussing uncertainties related to its strategy, data assets and market environment.
Current Reports on Form 8-K document specific material events. Forian has used 8-K filings to disclose changes in independent registered public accounting firms, including the dismissal of CBIZ CPAs P.C. and the appointment of BDO USA, P.C., along with discussion of previously identified material weaknesses in internal control over financial reporting and related restatements. Other 8-Ks report financial results for particular quarters and describe proposals and governance actions, such as the Board’s receipt of an unsolicited, preliminary, non-binding proposal to take the company private and the formation of a Special Committee to evaluate that proposal.
Proxy materials, including the Definitive Proxy Statement (DEF 14A) filed on December 15, 2025, provide insight into Forian’s corporate governance and strategic considerations. In that proxy statement, the company calls a Special Meeting of Stockholders to vote on redomiciling from Delaware to Maryland through a statutory conversion and on potential adjournments of the meeting to solicit additional proxies. The document explains the Board’s and Special Committee’s reasoning and outlines how the redomiciliation relates to the evaluation of a take-private offer and other potential transactions.
On Stock Titan, these filings are updated as they appear on the SEC’s EDGAR system. AI-powered tools can help summarize lengthy documents, highlight key changes in financial performance, identify governance and control issues, and surface items such as revenue recognition discussions, internal control assessments and details of strategic proposals. Users can also review ownership and governance information contained in proxy statements and track how Forian’s disclosures evolve across reporting periods.
Forian Inc. filed Amendment No. 1 to its Schedule 14D-9 to supplement its recommendation regarding the cash tender offer by 2025 Acquisition Company, LLC and Bravo Merger Sub, Inc. to acquire all outstanding common shares at $2.17 per share. The amendment adds director and officer background (Schedule I), describes agreements among certain stockholder consortium members and Parent (including a Contribution Agreement resulting in Parent owning 21,991,929 Shares, or 70.39% of issued and outstanding shares), and discloses an Equity Commitment Letter in which a Sponsor committed up to $5,500,000 to fund the Offer and Merger. The filing also states certain current executives (including Max Wygod, Michael Vesey, and Caroline McGrail) are understood to have roles with the Surviving Corporation and summarizes selected valuation analyses performed by Houlihan Lokey.
Forian Inc. is subject to a cash tender offer by 2025 Acquisition Company, LLC and its wholly owned subsidiary Bravo Merger Sub, Inc. to acquire the remaining public common shares for $2.17 per share, payable net in cash on the terms in the Offer to Purchase and Letter of Transmittal.
The filing amends the Schedule TO to add consolidated historical financials for Forian: $30.26M revenue and a $2.87M net loss for year ended December 31, 2025; $12.9M cash and $18.65M marketable securities at year-end. The Buyer Parties beneficially own approximately 70.61% of Forian; completion would increase their ownership to 100% and make Forian an indirect wholly owned subsidiary.
Forian Inc. filed Amendment No. 1 to its annual report for the year ended December 31, 2025 to add detailed Part III disclosures on directors, executive officers, compensation, ownership and auditor matters, plus updated officer certifications.
The company reported an aggregate market value of common stock held by non‑affiliates of about $34 million as of June 30, 2025 and 31,240,882 common shares outstanding as of April 27, 2026. Governance disclosures show a mostly independent board with specialized healthcare, technology and finance backgrounds, and outline its code of ethics and insider trading policy.
Compensation tables show 2025 total pay of $461,000 for CEO Max Wygod, $965,672 for Chief Strategy Officer Adam Dublin and $933,066 for CFO Michael Vesey, including equity awards and, for the CFO, a performance bonus. Ownership data highlight that 2025 Acquisition Company, LLC and related insiders beneficially own over 70% of the common stock, indicating highly concentrated control.
Forian Inc. responds to a cash tender offer and proposed two-step merger under a Merger Agreement dated April 2, 2026. Parent and Purchaser have offered $2.17 per share in cash in a tender offer that, if accepted and conditions met, will be followed by a merger that will take Forian private.
The filing discloses governance steps, treatment of equity awards (e.g., cash‑out of vested in‑the‑money options and RSUs), that a consortium beneficially owned ~70.39% as of April 15, 2026, and timeline anchors including an initial Offer expiration of one minute after 11:59 p.m. ET on May 14, 2026.
Forian Inc. has been the target of a cash tender offer by Bravo Merger Sub, Inc., a subsidiary of 2025 Acquisition Company, LLC, to purchase all issued and outstanding common shares for $2.17 per Share. The Offer to Purchase is dated April 16, 2026 and is filed on Schedule TO. According to the filing, there were 31,241,760 Shares issued and outstanding as of March 31, 2026.
The tender does not include Shares already owned by the buyer parties (the "Excluded Shares") and is being made on the terms set forth in the Offer to Purchase and the Letter of Transmittal, each incorporated by reference. The Agreement and Plan of Merger dated April 2, 2026 is attached as an exhibit and governs the back-end merger mechanics.
Forian Inc.’s largest shareholder group has reorganized its holdings through a new Contribution Agreement. Max C. Wygod, Emily Bushnell and related Wygod family trusts contributed all of their Forian common shares to a holding entity referred to as Parent, receiving an equivalent number of Parent common units.
Following this internal restructuring, the reporting persons are deemed to beneficially own 21,991,929 Forian shares, representing 70.5% of the company’s common stock based on 31,208,751 shares outstanding as of March 25, 2026. Voting and dispositive power over these shares is reported as shared among the group members.
Forian Inc. investors led by 2025 Acquisition Company, LLC and related trusts, funds and individuals have filed Amendment No. 3 to their Schedule 13D, reporting collective beneficial ownership of 21,991,929 shares of common stock, or 70.5% of Forian, based on 31,208,751 shares outstanding as of March 25, 2026.
On April 15, 2026, these shareholders entered into a Contribution Agreement under which each contributor transferred all of their Forian shares to a holding entity referred to as Parent in exchange for an equal number of Parent common units. As a result, Parent now holds the shares, and each contributor is deemed to beneficially own the full amount held by Parent, subject to individual disclaimers of beneficial ownership where noted.
The filing also adds several new investors, including Stephen Rich, Kerry Smith, Bradley Khouri, Joe Luter and The Trustees of Union College, to the existing shareholder Consortium. Due to the Consortium Agreement, its members may be deemed to form a group under Section 13(d)(3), collectively reporting the 70.5% stake while expressly disclaiming beneficial ownership of shares beyond those each has individually reported.
Forian Inc. is the target of a planned cash tender offer by 2025 Acquisition Company, LLC and its subsidiary Bravo Merger Sub, Inc. pursuant to an Agreement and Plan of Merger dated April 2, 2026. The announcement states the tender offer has not commenced and that formal tender offer materials (Schedule TO) and the company’s Solicitation/Recommendation Statement (Schedule 14D-9) will be filed at commencement. Shareholders are urged to read those documents when available; materials will be posted free on the SEC website and provided at no charge.
Forian Inc. has entered into a definitive merger agreement under which a consortium-led vehicle, 2025 Acquisition Company, LLC, will acquire Forian through a tender offer followed by a merger. Each outstanding common share will be converted into the right to receive $2.17 in cash, without interest and subject to tax withholding.
The filing details an amended consortium agreement, adds new consortium members, and describes an equity commitment letter under which a Wygod/Bushnell family trust has committed up to $5.5 million of equity funding to support closing payments. Completion of the offer and subsequent merger is subject to customary conditions, including a minimum tender of more than 50% of outstanding shares and the absence of a continuing Company Material Adverse Effect.
Forian Inc. is the subject of a planned going-private cash merger led by a consortium affiliated with Max Wygod. The reporting persons, including Max C. Wygod, Emily Bushnell and Wygod family trusts, report beneficial ownership stakes such as 12.4% and 11% of Forian’s common stock.
On April 2, 2026, a special purpose vehicle affiliated with Max Wygod and Bravo Merger Sub, Inc. signed a Merger Agreement with Forian. After a tender offer, Forian will merge into the buyer group and become a wholly owned subsidiary, with each outstanding share (other than specified excluded shares) converted into the right to receive $2.17 in cash per share, subject to appraisal rights and tax withholding.
A Wygod family trust committed up to $5,500,000 of equity financing to fund the closing payments. Closing is conditioned on more than 50% of shares being tendered (including existing buyer holdings), the accuracy of certain representations, Forian’s compliance with covenants, absence of a continuing Company Material Adverse Effect, and no blocking court orders.